MTOR and non-small cell lung carcinoma: Since in non-small cell lung cancer cell lines the BGT226-dependent modulation of PI3K/Akt/mTOR signal axis has been demonstrated [11], we determined whether this drug also affected downstream signal transduction factors that promote PI3K/Akt/mTOR-mediated cell survival.